- Home
- ZURA vs WALD Comparison
ZURA vs WALD Comparison
Compare ZURA & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZURA | WALD |
|---|---|---|
| Founded | 2022 | 1988 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 246.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ZURA | WALD |
|---|---|---|
| Price | $6.36 | $1.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $11.38 | $4.30 |
| AVG Volume (30 Days) | ★ 872.7K | 65.9K |
| Earning Date | 11-13-2025 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $274,560,000.00 |
| Revenue This Year | N/A | $2.69 |
| Revenue Next Year | N/A | $10.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.22 |
| 52 Week Low | $0.97 | $1.45 |
| 52 Week High | $6.63 | $3.63 |
Technical Indicators
Market Signals| Indicator | ZURA | WALD |
|---|---|---|
| Relative Strength Index (RSI) | 63.92 | 62.15 |
| Support Level | $5.46 | $1.50 |
| Resistance Level | $6.62 | $1.85 |
| Average True Range (ATR) | 0.64 | 0.14 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 88.09 | 98.18 |
Price Performance
Historical ComparisonAbout ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.